Hepatocytes Are Resistant to Cell Death From Canonical and Non-Canonical Inflammasome-Activated Pyroptosis.
Hepatocytes Are Resistant to Cell Death From Canonical and Non-Canonical Inflammasome-Activated Pyroptosis.
复制标题
DOI:
10.1016/j.jcmgh.2021.11.009
复制
发表时间:
2022
影响因子:
7.2
通讯作者:
Scott MJ
中科院分区:
文献类型:
--
作者:
Sun P;Zhong J;Liao H;Loughran P;Mulla J;Fu G;Tang D;Fan J;Billiar TR;Gao W;Scott MJ
Pyroptosis, gasdermin-mediated programmed cell death, is readily induced in macrophages by activation of the canonical inflammasome (caspase-1) or by intracellular lipopolysaccharide (LPS)-mediated non-canonical inflammasome (caspase-11) activation. However, whether pyroptosis is induced similarly in hepatocytes is still largely controversial but highly relevant to liver pathologies such as alcoholic/nonalcoholic liver disease, drug-induced liver injury, ischemia-reperfusion and liver transplant injury, or organ damage secondary to sepsis. In this study we found that hepatocytes activate and cleave gasdermin-D (GSDMD) at low levels after treatment with LPS. Overexpression of caspase-1 or caspase-11 p10/p20 activated domains was able to induce typical GSDMD-dependent pyroptosis in hepatocytes both in vitro and in vivo. However, morphologic features of pyroptosis in macrophages (eg, pyroptotic bodies, cell flattening, loss of cell structure) did not occur in pyroptotic hepatocytes, with cell structure remaining relatively intact despite the cell membrane being breached. Our results suggest that hepatocytes activate pyroptosis pathways and cleave GSDMD, but this does not result in cell rupture and confer the same pyroptotic morphologic changes as previously reported in macrophages. This is true even with caspase-1 or caspase-11 artificial overexpression way above levels seen endogenously even after priming or in pathologic conditions. Our novel findings characterize hepatocyte morphology in pyroptosis and suggest alternative use for canonical/non-canonical inflammasome activation/signaling and subsequent GSDMD cleavage because there is no rapid cell death as in macrophages. Improved understanding and recognition of the role of these pathways in hepatocytes may result in novel therapeutics for a range of liver diseases.
登录
查看更多内容
影响因子:
25.7
作者:
Gaul S;Leszczynska A;Alegre F;Kaufmann B;Johnson CD;Adams LA;Wree A;Damm G;Seehofer D;Calvente CJ;Povero D;Kisseleva T;Eguchi A;McGeough MD;Hoffman HM;Pelegrin P;Laufs U;Feldstein AE
通讯作者:
Feldstein AE
DOI:
10.1002/hep.30249
发表时间:
2019-03
期刊:
Hepatology (Baltimore, Md.)
影响因子:
--
作者:
Ambade A;Lowe P;Kodys K;Catalano D;Gyongyosi B;Cho Y;Iracheta-Vellve A;Adejumo A;Saha B;Calenda C;Mehta J;Lefebvre E;Vig P;Szabo G
通讯作者:
Szabo G
影响因子:
13.5
作者:
Csak, Timea;Ganz, Michal;Pespisa, Justin;Kodys, Karen;Dolganiuc, Angela;Szabo, Gyongyi
通讯作者:
Szabo, Gyongyi
DOI:
10.1126/science.1240988
发表时间:
2013-09-13
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Hagar JA;Powell DA;Aachoui Y;Ernst RK;Miao EA
通讯作者:
Miao EA
DOI:
10.4049/jimmunol.1402658
发表时间:
2015-04-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Katsnelson MA;Rucker LG;Russo HM;Dubyak GR
通讯作者:
Dubyak GR